Cargando…

Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells()

Currently MedImmune manufactures cold-adapted (ca) live, attenuated influenza vaccine (LAIV) from specific-pathogen free (SPF) chicken eggs. Difficulties in production scale-up and potential exposure of chicken flocks to avian influenza viruses especially in the event of a pandemic influenza outbrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Althaf I., Cordeiro, Melissa, Sevilla, Elizabeth, Liu, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172923/
https://www.ncbi.nlm.nih.gov/pubmed/20307595
http://dx.doi.org/10.1016/j.vaccine.2010.03.005
_version_ 1783524353384644608
author Hussain, Althaf I.
Cordeiro, Melissa
Sevilla, Elizabeth
Liu, Jonathan
author_facet Hussain, Althaf I.
Cordeiro, Melissa
Sevilla, Elizabeth
Liu, Jonathan
author_sort Hussain, Althaf I.
collection PubMed
description Currently MedImmune manufactures cold-adapted (ca) live, attenuated influenza vaccine (LAIV) from specific-pathogen free (SPF) chicken eggs. Difficulties in production scale-up and potential exposure of chicken flocks to avian influenza viruses especially in the event of a pandemic influenza outbreak have prompted evaluation and development of alternative non-egg based influenza vaccine manufacturing technologies. As part of MedImmune's effort to develop the live attenuated influenza vaccine (LAIV) using cell culture production technologies we have investigated the use of high yielding, cloned MDCK cells as a substrate for vaccine production by assessing host range and virus replication of influenza virus produced from both SPF egg and MDCK cell production technologies. In addition to cloned MDCK cells the indicator cell lines used to evaluate the impact of producing LAIV in cells on host range and replication included two human cell lines: human lung carcinoma (A549) cells and human muco-epidermoid bronchiolar carcinoma (NCI H292) cells. The influenza viruses used to infect the indicators cell lines represented both the egg and cell culture manufacturing processes and included virus strains that composed the 2006–2007 influenza seasonal trivalent vaccine (A/New Caledonia/20/99 (H1N1), A/Wisconsin/67/05 (H3N2) and B/Malaysia/2506/04). Results from this study demonstrate remarkable similarity between influenza viruses representing the current commercial egg produced and developmental MDCK cell produced vaccine production platforms. MedImmune's high yielding cloned MDCK cells used for the cell culture based vaccine production were highly permissive to both egg and cell produced ca attenuated influenza viruses. Both the A549 and NCI H292 cells regardless of production system were less permissive to influenza A and B viruses than the MDCK cells. Irrespective of the indicator cell line used the replication properties were similar between egg and the cell produced influenza viruses. Based on these study results we conclude that the MDCK cell produced and egg produced vaccine strains are highly comparable.
format Online
Article
Text
id pubmed-7172923
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71729232020-04-22 Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells() Hussain, Althaf I. Cordeiro, Melissa Sevilla, Elizabeth Liu, Jonathan Vaccine Article Currently MedImmune manufactures cold-adapted (ca) live, attenuated influenza vaccine (LAIV) from specific-pathogen free (SPF) chicken eggs. Difficulties in production scale-up and potential exposure of chicken flocks to avian influenza viruses especially in the event of a pandemic influenza outbreak have prompted evaluation and development of alternative non-egg based influenza vaccine manufacturing technologies. As part of MedImmune's effort to develop the live attenuated influenza vaccine (LAIV) using cell culture production technologies we have investigated the use of high yielding, cloned MDCK cells as a substrate for vaccine production by assessing host range and virus replication of influenza virus produced from both SPF egg and MDCK cell production technologies. In addition to cloned MDCK cells the indicator cell lines used to evaluate the impact of producing LAIV in cells on host range and replication included two human cell lines: human lung carcinoma (A549) cells and human muco-epidermoid bronchiolar carcinoma (NCI H292) cells. The influenza viruses used to infect the indicators cell lines represented both the egg and cell culture manufacturing processes and included virus strains that composed the 2006–2007 influenza seasonal trivalent vaccine (A/New Caledonia/20/99 (H1N1), A/Wisconsin/67/05 (H3N2) and B/Malaysia/2506/04). Results from this study demonstrate remarkable similarity between influenza viruses representing the current commercial egg produced and developmental MDCK cell produced vaccine production platforms. MedImmune's high yielding cloned MDCK cells used for the cell culture based vaccine production were highly permissive to both egg and cell produced ca attenuated influenza viruses. Both the A549 and NCI H292 cells regardless of production system were less permissive to influenza A and B viruses than the MDCK cells. Irrespective of the indicator cell line used the replication properties were similar between egg and the cell produced influenza viruses. Based on these study results we conclude that the MDCK cell produced and egg produced vaccine strains are highly comparable. Elsevier Ltd. 2010-05-14 2010-03-20 /pmc/articles/PMC7172923/ /pubmed/20307595 http://dx.doi.org/10.1016/j.vaccine.2010.03.005 Text en Copyright © 2010 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Hussain, Althaf I.
Cordeiro, Melissa
Sevilla, Elizabeth
Liu, Jonathan
Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells()
title Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells()
title_full Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells()
title_fullStr Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells()
title_full_unstemmed Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells()
title_short Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells()
title_sort comparison of egg and high yielding mdck cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172923/
https://www.ncbi.nlm.nih.gov/pubmed/20307595
http://dx.doi.org/10.1016/j.vaccine.2010.03.005
work_keys_str_mv AT hussainalthafi comparisonofeggandhighyieldingmdckcellderivedliveattenuatedinfluenzavirusforcommercialproductionoftrivalentinfluenzavaccineinvitrocellsusceptibilityandinfluenzavirusreplicationkineticsinpermissiveandsemipermissivecells
AT cordeiromelissa comparisonofeggandhighyieldingmdckcellderivedliveattenuatedinfluenzavirusforcommercialproductionoftrivalentinfluenzavaccineinvitrocellsusceptibilityandinfluenzavirusreplicationkineticsinpermissiveandsemipermissivecells
AT sevillaelizabeth comparisonofeggandhighyieldingmdckcellderivedliveattenuatedinfluenzavirusforcommercialproductionoftrivalentinfluenzavaccineinvitrocellsusceptibilityandinfluenzavirusreplicationkineticsinpermissiveandsemipermissivecells
AT liujonathan comparisonofeggandhighyieldingmdckcellderivedliveattenuatedinfluenzavirusforcommercialproductionoftrivalentinfluenzavaccineinvitrocellsusceptibilityandinfluenzavirusreplicationkineticsinpermissiveandsemipermissivecells